RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Lotus Pharmaceuticals Stock

Lotus Pharmaceuticals ROE 2024

Lotus Pharmaceuticals ROE

0

Ticker

LTUS

ISIN

US5457152032

WKN

A1H5XJ

In 2024, Lotus Pharmaceuticals's return on equity (ROE) was 0, a 0% increase from the 0 ROE in the previous year.

Lotus Pharmaceuticals Aktienanalyse

What does Lotus Pharmaceuticals do?

The company Lotus Pharmaceuticals Inc was founded in 1976 and is based in Taiwan. The company operates in the pharmaceutical products sector and currently employs approximately 1,100 employees. Over the years, the company has become one of the leading providers of medications in the Taiwanese market. Lotus Pharma's business model is focused on the production, marketing, and sale of pharmaceutical products for the Taiwanese market. The company operates a comprehensive research and development department that specializes in the development of new medications for specific therapeutic applications. This department is also responsible for the continuous improvement and adaptation of existing medications. Lotus Pharma operates a range of different divisions within its organization. These include the marketing and distribution of innovative and generic medications, the sale of medical devices, and the development and production of natural remedies. Each division is focused on a specific group of customers and products. Lotus Pharma's product offering includes a wide range of pharmaceutical products developed for various therapeutic applications. These include medications for the treatment of cardiovascular diseases, diabetes, cancer, infectious diseases, and other acute and chronic illnesses. All products have been developed and manufactured in accordance with applicable international quality standards. An important product of Lotus Pharma is the antithrombotic medication "Plavix," which is used to prevent blood clots in cases of heart attack and stroke. Lotus Pharma is the only authorized manufacturer of this medication for the Taiwanese market, giving it a strong market position in this area. In recent years, Lotus Pharma has also expanded its offering to include natural remedies. These are increasingly in demand by a growing number of people interested in alternative treatment methods. These products have all been developed based on traditional Chinese medicine principles and are based on natural ingredients. Lotus Pharma aims to improve the health and well-being of its customers. The company strives to offer high-quality pharmaceutical products that meet the needs of its customers and help them achieve their health goals. Through its comprehensive research and development efforts, as well as its top-notch production and marketing, Lotus Pharma has become a key player in the Taiwanese market and is expected to continue growing in the coming years. Lotus Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Lotus Pharmaceuticals's Return on Equity (ROE)

Lotus Pharmaceuticals's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Lotus Pharmaceuticals's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Lotus Pharmaceuticals's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Lotus Pharmaceuticals’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Lotus Pharmaceuticals stock

What is the ROE (Return on Equity) of Lotus Pharmaceuticals this year?

The ROE of Lotus Pharmaceuticals this year is 0 undefined.

How has the Return on Equity (ROE) of Lotus Pharmaceuticals developed compared to the previous year?

The ROE of Lotus Pharmaceuticals has increased by 0% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Lotus Pharmaceuticals?

A high ROE indicates that Lotus Pharmaceuticals generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Lotus Pharmaceuticals?

A low ROE can indicate that Lotus Pharmaceuticals is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Lotus Pharmaceuticals affect the company?

A change in ROE (Return on Equity) of Lotus Pharmaceuticals can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Lotus Pharmaceuticals?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Lotus Pharmaceuticals?

Some factors that can influence Lotus Pharmaceuticals's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Lotus Pharmaceuticals pay?

Over the past 12 months, Lotus Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Lotus Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Lotus Pharmaceuticals?

The current dividend yield of Lotus Pharmaceuticals is .

When does Lotus Pharmaceuticals pay dividends?

Lotus Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Lotus Pharmaceuticals?

Lotus Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Lotus Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Lotus Pharmaceuticals located?

Lotus Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lotus Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lotus Pharmaceuticals from 9/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/28/2024.

When did Lotus Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/28/2024.

What was the dividend of Lotus Pharmaceuticals in the year 2023?

In the year 2023, Lotus Pharmaceuticals distributed 0 USD as dividends.

In which currency does Lotus Pharmaceuticals pay out the dividend?

The dividends of Lotus Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Lotus Pharmaceuticals

Our stock analysis for Lotus Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lotus Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.